Lyra TherapeuticsLYRA
13F holders, Q1 2024 (March 31)79holders
4famous investors
$6.22avg. 13F price*
At the end of Q1 2024, 79 institutions reported holding Lyra Therapeutics Inc. (LYRA) in their 13F filings. The largest holders were Perceptive Advisors LLC ($79.4M), Citadel Advisors ($27.0M) and Nantahala Capital Management, LLC ($17.5M). 4 famous investors held it, including Steve Cohen (0.1% of Point72 Asset Management's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Lyra Therapeutics Inc.
- CUSIP
- 55234L105
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 24 | $26.8M |
| Exits | 6 | $6.2M |
Ownership 79 holders
| Perceptive Advisors LLC | 1.40% | No change | 12,757,562 | $79.4M |
| Citadel Advisors | 0.03% | Add +51.6% | 4,339,101 | $27.0M |
| Nantahala Capital Management, LLC | 1.73% | Reduce -30.4% | 2,820,982 | $17.5M |
| Samsara Biocapital, LLC | 2.68% | No change | 2,780,261 | $17.3M |
| Point72 Asset Management | 0.05% | Reduce -8.6% | 2,742,460 | $17.1M |
| Venrock Adviser, LLC | 0.76% | Add +0.0% | 2,576,093 | $16.0M |
| Vanguard Group Inc. | 0.00% | Add +38.3% | 1,481,481 | $9.2M |
| Pura Vida Investments, LLC | 5.99% | No change | 1,413,242 | $8.8M |
| Rosalind Advisors, Inc. | 6.66% | Reduce -39.4% | 1,144,524 | $7.1M |
| Ikarian Capital, LLC | 1.79% | Reduce -15.8% | 1,056,829 | $6.6M |
| Ally Bridge Group (NY) LLC | 3.47% | New | 1,003,741 | $6.2M |
| Tri Locum Partners LP | 2.11% | New | 978,793 | $6.1M |
| Vestal Point Capital, LP | 0.41% | Reduce -73.3% | 800,000 | $5.0M |
| Verition Fund Management LLC | 0.05% | New | 768,214 | $4.8M |
| Laurion Capital Management LP | 0.13% | Add +1662.8% | 747,827 | $4.7M |
| Woodline Partners LP | 0.04% | Add +12.8% | 676,554 | $4.2M |
| Parkman Healthcare Partners LLC | 0.49% | Reduce -14.9% | 642,245 | $4.0M |
| Ensign Peak Advisors, Inc | 0.01% | Add +96.1% | 591,311 | $3.7M |
| Invesco Ltd. | 0.00% | New | 555,233 | $3.5M |
| Walleye Capital LLC | 0.04% | Add +3419.4% | 528,118 | $3.3M |
| Millennium Management | 0.00% | Add +24.6% | 406,121 | $2.5M |
| Geode Capital Management, LLC | 0.00% | Add +6.8% | 359,431 | $2.2M |
| Schonfeld Strategic Advisors LLC | 0.02% | Add +756.6% | 357,319 | $2.2M |
| Susquehanna International Group, LLP | 0.00% | Add +32.3% | 343,322 | $2.1M |
| Goldman Sachs Group Inc. | 0.00% | Add +2461.9% | 334,665 | $2.1M |
| Hudson Bay Capital Management LP | 0.02% | New | 250,000 | $1.6M |
| Boothbay Fund Management, LLC | 0.05% | Reduce -6.9% | 232,670 | $1.4M |
| Dimensional Fund Advisors LP | 0.00% | Add +69.6% | 190,986 | $1.2M |
| Two Sigma Investments, LP | 0.00% | Add +38.6% | 183,743 | $1.1M |
| Acuta Capital Partners, LLC | 0.70% | New | 173,320 | $1.1M |
| Bank of America Corp. | 0.00% | Add +10.3% | 159,597 | $993K |
| Jane Street Group, LLC | 0.00% | Add +101.5% | 157,703 | $981K |
| BlackRock Inc. | 0.00% | Add +37.1% | 151,919 | $945K |
| Superstring Capital Management LP | 0.60% | New | 145,284 | $904K |
| Two Sigma Advisers, LP | 0.00% | Add +183.8% | 143,900 | $895K |
| Qube Research & Technologies Ltd | 0.00% | Add +137.9% | 131,902 | $820K |
| State Street Corp. | 0.00% | Add +15.6% | 126,180 | $785K |
| Clearline Capital LP | 0.07% | No change | 119,128 | $741K |
| Citigroup Inc. | 0.00% | Reduce -4.5% | 118,875 | $739K |
| JPMorgan Chase & Co. | 0.00% | Add +229.8% | 109,405 | $680K |
| HRT Financial LP | 0.00% | New | 98,525 | $612K |
| Man Group plc | 0.00% | Add +137.6% | 90,283 | $562K |
| Bridgeway Capital Management, LLC | 0.01% | Reduce -38.8% | 86,800 | $540K |
| Marathon Trading Investment Management LLC | 0.17% | New | 67,010 | $417K |
| Morgan Stanley | 0.00% | New | 64,392 | $401K |
| Northern Trust Corp. | 0.00% | Reduce -1.7% | 60,495 | $376K |
| Renaissance Technologies | 0.00% | Add +15.9% | 50,900 | $317K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | New | 41,563 | $259K |
| Barclays PLC | 0.00% | No change | 32,817 | $204K |
| ExodusPoint Capital Management, LP | 0.00% | Add +10.6% | 32,118 | $200K |
| Letko, Brosseau & Associates Inc. | 0.00% | No change | 31,900 | $198K |
| Balyasny Asset Management L.P. | 0.00% | Add +9.3% | 31,459 | $196K |
| American Century Companies Inc. | 0.00% | New | 25,778 | $160K |
| Occudo Quantitative Strategies LP | 0.02% | New | 22,820 | $142K |
| OMERS ADMINISTRATION Corp | 0.00% | New | 22,200 | $138K |
| Cubist Systematic Strategies, LLC | 0.00% | Reduce -28.6% | 21,160 | $132K |
| Y-Intercept (Hong Kong) Ltd | 0.01% | Add +67.2% | 20,531 | $128K |
| Jump Financial, LLC | 0.00% | Add +20.6% | 20,187 | $126K |
| Prelude Capital Management, LLC | 0.01% | New | 15,400 | $96K |
| Brevan Howard Capital Management LP | 0.01% | New | 14,042 | $87K |
| Bank of Montreal | 0.00% | New | 13,900 | $82K |
| DLK Investment Management, LLC | 0.03% | No change | 12,000 | $75K |
| Virtu Financial LLC | 0.01% | New | 11,928 | $74K |
| Squarepoint Ops LLC | 0.00% | New | 11,670 | $73K |
| Jefferies Financial Group Inc. | 0.00% | New | 11,400 | $71K |
| Engineers Gate Manager LP | 0.00% | New | 10,718 | $67K |
| Heritage Wealth Management, Inc./Texas | 0.04% | No change | 10,000 | $62K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +277.7% | 8,921 | $55K |
| Catalyst Funds Management Pty Ltd | 0.01% | — | 8,200 | $51K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | Add +774.4% | 5,710 | $36K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,000 | $12K |
| Comerica Bank | 0.00% | No change | 1,159 | $7K |
| Royal Bank of Canada | 0.00% | Reduce -80.1% | 654 | $4K |
| Rhumbline Advisers | 0.00% | No change | 296 | $2K |
| Wells Fargo & Company | 0.00% | Add +1.6% | 251 | $2K |
| National Bank of Canada | 0.00% | New | 3,700 | $1K |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 100 | $622 |
| UBS Group AG | 0.00% | Reduce -99.6% | 18 | $112 |
| Macquarie Group Ltd. | 0.00% | New | 1,375 | $9 |
"% of holder's portfolio" is LYRA's weight in each manager's 13F, not the share of Lyra Therapeutics Inc. the manager owns.